IGM Biosciences
(NASDAQ:IGMS)
$18.37
0.34[1.89%]
At close: Jul 1
$18.37
00
After Hours: 4:00PM EDT
Day High/Low17.79 - 18.93
52 Week High/Low12.67 - 93.98
Open / Close18.01 / 18.37
Float / Outstanding9.9M / 42.5M
Vol / Avg.128.1K / 384.4K
Mkt Cap781.2M
P/E-
50d Avg. Price16.86
Div / Yield-
Payout Ratio-
EPS-1.53
Total Float9.9M

IGM Biosciences (NASDAQ:IGMS), Quotes and News Summary

IGM Biosciences (NASDAQ: IGMS)

Day High/Low17.79 - 18.93
52 Week High/Low12.67 - 93.98
Open / Close18.01 / 18.37
Float / Outstanding9.9M / 42.5M
Vol / Avg.128.1K / 384.4K
Mkt Cap781.2M
P/E-
50d Avg. Price16.86
Div / Yield-
Payout Ratio-
EPS-1.53
Total Float9.9M
Benzinga - May 9, 2022, 5:22PM
Benzinga - Mar 29, 2022, 7:42AM
load more
Sector: Health Care.Industry: Biotechnology
IGM Biosciences Inc is a biotechnology company engaged in the development of IgM antibody therapeutics for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. Its IgM antibody technology platform is suited for developing T cell engagers, receptor cross-linking agonists, and targeted cytokines. Its product candidate, IGM-2323, is a bispecific T cell engaging IgM antibody targeting CD20 and CD3 protein, IGM-8444, a combination with a chemotherapeutic agent such as irinotecan, gemcitabine, or venetoclax, and IGM-7354, a bispecific IgM antibody delivering interleukin-15 (IL-15) cytokines to PD-L1 expressing cells for the treatment of patients with solid and hematologic malignancies.

Earnings

see more
Q2 2022Est.ActualSurprise
EPS
(EXPECTED)2022-08-08
REV
Q1 2022Est.ActualSurprise
EPS-1.610-1.530 0.0800
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

IGM Biosciences Questions & Answers

Q
How do I buy IGM Biosciences (IGMS) stock?
A

You can purchase shares of IGM Biosciences (NASDAQ: IGMS) through any online brokerage.

View our list of the best stock brokerages.

Q
Who are IGM Biosciences's (IGMS) competitors?
Q
What is the target price for IGM Biosciences (IGMS) stock?
A

The latest price target for IGM Biosciences (NASDAQ: IGMS) was reported by Baird on Wednesday, June 1, 2022. The analyst firm set a price target for 31.00 expecting IGMS to rise to within 12 months (a possible 68.75% upside). 15 analyst firms have reported ratings in the last year.

Q
Current Stock Price for IGM Biosciences (IGMS)?
A

The stock price for IGM Biosciences (NASDAQ: IGMS) is $18.37 last updated July 1, 2022, 8:00 PM UTC.

Q
Does IGM Biosciences (IGMS) pay a dividend?
A

There are no upcoming dividends for IGM Biosciences.

Q
When is IGM Biosciences (NASDAQ:IGMS) reporting earnings?
A

IGM Biosciences’s Q2 earnings are confirmed for Monday, August 8, 2022.

Q
Is IGM Biosciences (IGMS) going to split?
A

There is no upcoming split for IGM Biosciences.

Q
What sector and industry does IGM Biosciences (IGMS) operate in?
A

IGM Biosciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.